From: MTA1 promotes metastasis of MPM via suppression of E-cadherin
Characteristics | All patients | MTA1 expression | P | Â | |
---|---|---|---|---|---|
Low | High | χ2 | |||
N | 65 | 25 | 40 | Â | Â |
Sex | Â | Â | Â | 0.455 | 0.559 |
 Male | 35 | 12 | 23 |  |  |
 Female | 30 | 13 | 17 |  |  |
Age (years) | Â | Â | Â | 0.842 | 0.040 |
 <60 | 27 | 10 | 17 |  |  |
 ≥60 | 38 | 15 | 23 |  |  |
Histology | Â | Â | Â | 0.038 | 6.524 |
 Epithelioid | 20 | 13 | 7 |  |  |
 Sarcomatoid | 25 | 7 | 18 |  |  |
 Biphasic | 20 | 5 | 15 |  |  |
TNM stagea | Â | Â | Â | 0.003 | 8.990 |
 I/II | 29 | 17 | 12 |  |  |
 III/IV | 36 | 8 | 28 |  |  |
Lymph node Metastasis | Â | Â | Â | 0.001 | 11.714 |
 Yes | 38 | 8 | 30 |  |  |
 No | 27 | 17 | 10 |  |  |
Distant Metastasis | Â | Â | Â | <0.001 | 14.562 |
 Yes | 35 | 6 | 29 |  |  |
 No | 30 | 19 | 11 |  |  |